Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence
Cc. Park et al., Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence, J CL ONCOL, 18(8), 2000, pp. 1668-1675
Purpose: To examine the relationship between pathologic margin status and o
utcome at 8 years after breast-conserving surgery and radiation therapy,
Patients and Methods: The study population comprised 533 patients with inte
rnational Union Against Cancer/American Joint Committee on Cancer clinical
stage I or II breast cancer who had assessable margins, who received at lea
st 60 Gy to the primary tumor bed, and who had more than 8 years of potenti
al follow-up. Each margin was scored (according to the presence of inversiv
e or in situ disease that touched the inked surgical margin) as one of the
following: negative, close, focally positive, or extensively positive. Outc
ome at 8 years was calculated using crude rates of first site of failure. A
polychotomous logistic regression analysis was performed, Median follow-vp
time was 127 months.
Results: At 8 years, patients with close margins and those with negative ma
rgins both held a rate of local recurrence (LR) of: 7%, patients with exten
sively positive margins had an LR rate of 27%, whereas patients with focall
y positive margins had an intermediate rate of LR of 14%, In the polychotom
ous logistic regression model, margin status and the use of systemic therap
y were the only two variables that had significant effects on the risk rati
o of LR to remaining alive and free of disease, Among the 45 patients with
focally positive margins who received systemic therapy, the crude LR rate w
as 7% at 8 years (95% confidence interval, 1% to 20%),
Conclusion: Pathologic margin status and the use of adjuvant systemic thera
py are the most important factors associated with LR among patients treated
with breast-conserving surgery and radiation therapy.
J Clin Oncol 88:1668-1675, (C) 2000 by American Society of Clinical Oncolog
y.